Vital Data for DDI Risk Mitigation

As use of prescriptions and drug combinations rise, the risk of drug-drug interactions (DDIs) increases. Testing and mitigation strategies help ensure safety, but for maximum effectiveness, data from sources like the FDA and EMA needs to be considered.

Learn how using regulatory data can lessen the threat of DDIs